Danny Wilbie
Impact in
Papers in
-
- CRISPR and Genetic Engineering 5
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 2
- Protein Degradation and Inhibitors 1
- Pluripotent Stem Cells Research 1
- Genetics 2
- Animal Genetics and Reproduction 1
- Co-authors
- Johanna Walther (4 shared papers)Enrico Mastrobattista (5 shared papers)Arto Urtti (1 shared paper)Tatu Lajunen (1 shared paper)Ossi Korhonen (1 shared paper)Tomasz Róg (1 shared paper)Marika Ruponen (1 shared paper)Alex Bunker (1 shared paper)
- Journals
- Pharmaceutics (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)PLoS ONE (1 paper)European Polymer Journal (1 paper)Journal of Controlled Release (1 paper)
- Partner nations
- NetherlandsFinlandGermany
In The Last Decade
Danny Wilbie
6 papers receiving 369 citations
Peers
Comparison fields: 5 of 56
- Business and International Management 20
- Aging 11
- Molecular Biology 289
- Biomaterials 39
- Pharmaceutical Science 13
Countries citing papers authored by Danny Wilbie
This map shows the geographic impact of Danny Wilbie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Wilbie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Wilbie more than expected).
Fields of papers citing papers by Danny Wilbie
This network shows the impact of papers produced by Danny Wilbie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Wilbie. The network helps show where Danny Wilbie may publish in the future.
Co-authors
The 20 scholars most cited alongside Danny Wilbie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 228 | |
| 2 | 2018 | 58 | |
| 3 | 2024 | 36 | |
| 4 | 2022 | 24 | |
| 5 | 2022 | 17 | |
| 6 | 2021 | 9 | |
| 7 | 2025 | 0 | |
| 8 | 2025 | 0 |
About Danny Wilbie
Danny Wilbie is a scholar working on Molecular Biology, Genetics, Ophthalmology, Business and International Management and Biomaterials, having authored 8 papers that have together received 372 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (5 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Retinal Diseases and Treatments (1 paper), Advanced Nanomaterials in Catalysis (1 paper), Animal Genetics and Reproduction (1 paper), Protein Degradation and Inhibitors (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Business and International Management (20 citations), Aging (11 citations), Molecular Biology (289 citations), Biomaterials (39 citations) and Pharmaceutical Science (13 citations). Danny Wilbie has collaborated with scholars based in Netherlands, Finland and Germany. Frequent co-authors include Johanna Walther, Enrico Mastrobattista, Arto Urtti, Tatu Lajunen, Ossi Korhonen, Tomasz Róg, Marika Ruponen, Alex Bunker, Naomi Benne and Olivier G. de Jong. Their work appears in journals such as Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, PLoS ONE, European Polymer Journal and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.